EU RESEARCHERS TO DEVELOP DRUGS TO FIGHT HOSPITAL SUPERBUGS
December 1st, 2008
BY KEITH NUTHALL
A EUROPEAN Union (EU)-funded research project commanding Euro 4.6 million in EU money is to develop antibiotics to combat highly drug-resistant bacteria pseudomonas aeruginosa. This accounts for a significant percentage of hospital-acquired infections, noted the European Commission. The AEROPATH project includes university scientists in Britain and Sweden, working with German biotech companies Lionex and MFD Diagnostics. P. aeroginosa is tough: it can grow in plain, distilled water, can tolerate many temperatures and resists high concentrations ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.